Health
Sky Labs Launches CART BP, a Ring-Type Cuffless Blood Pressure Monitor
App-based "Blood Pressure Calendar" enables 24-hour tracking, including
nighttime measurements
SEOUL, South Korea, Sept. 25, 2025 /PRNewswire/ -- Sky Labs announced the
official launch of CART BP, a ring-type personal blood pressure monitor
designed for everyday use.
ADVANCION PUBLISHES 2024 CORPORATE SUSTAINABILITY REPORT
Fourth annual report highlights continued progress in sustainable innovation, safety, and responsible resource stewardship BUFFALO GROVE, Ill., Sept. 25, 2025 /PRNewswire/ -- Advancion Corporation ("Advancion" or "Company"), a global leader in life science buffers and proprietary specialty ingre...
Suvoda and Greenphire complete brand integration with unified website and social media presence
CONSHOHOCKEN, Pa., Sept. 25, 2025 /PRNewswire/ -- Suvoda LLC
MindHYVE.ai™ Unveils ChironAI™: The World's First AGI-Powered Clinical Decision Support System, Redefining Healthcare Intelligence
NEWPORT BEACH, Calif., Sept. 24, 2025 /PRNewswire/ -- HYVE Labs™ and MindHYVE.ai™ proudly announce the global launch of ChironAI™, an autonomous, next-generation Clinical Decision Support (CDS) system powered by the revolutionary Ava-Healthcare™ AGI reasoning model. Designed from the ground up t...
Shaklee® Expands in New Zealand by Acquiring Modere® Assets and Product Rights Including Liquid Biocell® Collagen, Trim, and Natural Mineral Drink
MIAMI, Sept. 25, 2025 /PRNewswire/ -- Shaklee, a global leader and pioneer in the nutrition and wellness industry, is proud to announce the continued expansion of its international presence through the acquisition of select Modere assets inNew Zealand, via a wholly owned subsidiary. This strategi...
The Hidden Genetic Threat Putting 1 in 5 at Cardiovascular Disease Risk: Global Experts Call for Action on Elevated Lipoprotein(a)
* Cardiovascular disease (CVD) kills nearly 18 million people each year, more than all cancers combined1,2 * Elevated lipoprotein(a) or Lp(a), an inherited condition that raises CVD risk, affects 1 in 5 people worldwide but is rarely tested3 * New survey across Asia Pacific and Middle East s...
Hengrui Pharma and Glenmark Pharmaceuticals Enter Exclusive License Agreement for HER2 ADC Trastuzumab Rezetecan (SHR-A1811)
SHANGHAI, Sept. 24, 2025 /PRNewswire/ -- Hengrui Pharma (600276.SH; 01276.HK), a leading innovative global pharmaceutical company focused on scientific and technological innovation, announced today that it has entered into an exclusive license agreement with Glenmark Specialty S.A. (GSSA), a whol...
Demand for charitable services is increasing around the world, according to new Charities Aid Foundation research
LONDON, Sept. 24, 2025 /PRNewswire/ -- Charities around the world say that
demand for their organisation's services has increased over the last year,
according to new global research by theCharities Aid Foundation
Singapore International Agri-Food Week 2025 Returns with Focus on Sustainable and Resilient Food Systems in the Asia Pacific
SINGAPORE, Sept. 24, 2025 /PRNewswire/ -- The Singapore International Agri-Food Week (SIAW) 2025 returns from 3-6 November 2025 at the Sands Expo & Convention Centre, uniting global leaders and innovators under the theme 'Accelerating Climate Resilience inAsia-Pacific's Agri-Food System'. SIAW is...
Xinhua Silk Road: Guotai Haitong Securities hosts conference on biopharma and AI in E. China's Shanghai
BEIJING, Sept. 24, 2025 /PRNewswire/ -- The 2025 Shanghai pioneering industries conference, hosted by Guotai Haitong Securities, was recently held in east China's Shanghai. The event also featured the 14th pharmaceutical CEO forum and the 5th artificial intelligence (AI) conference. The event bro...
LifeSpan Portfolio Company Remedium Signs Landmark Deal with Eli Lilly
NORWALK, Conn., Sept. 24, 2025 /PRNewswire/ -- Lifespan Vision Ventures is pleased to announce that its portfolio company, Remedium Bio, Inc. ("Remedium"), has entered into a multi-target research and development collaboration with Eli Lilly and Company ("Lilly") focused on advancing innovative ...
TraceLink Delivers Intelligent Productivity Gains with OPUS Platform Expansion
BOSTON, Sept. 24, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, today announced powerful new capabilities in its Orchestration Platform for Universal Solutions (OPUS) designed to unlock unprecedented productivity...
LabConnect Partners with The Bracken Group to Expand Radiopharmaceutical Support Services
JOHNSON CITY, Tenn., Sept. 23, 2025 /PRNewswire/ -- LabConnect, a leading provider of global central laboratory and support services for clinical trials, announces a strategic collaboration with The Bracken Group to enhance its radiopharmaceutical support capabilities. As demand for radiopharmac...
Pictor Secures Funding to Accelerate U.S. Expansion through Partner-Informed Proteomics Solutions
CARLSBAD, Calif., Sept. 23, 2025 /PRNewswire/ -- Pictor Holdings Inc., a global leader in targeted, multiplex proteomics, today announced the close of a convertible note funding round led by existing investors. The raise underscores strong confidence in Pictor's strategic expansion and recent est...
Kemin Industries Acquires CJ Bio Subsidiary CJ Youtell Biotech
Specializing in enzymes and fermentation, the biotech company will transform the expansion of Kemin's global enzyme production capabilities DES MOINES, Iowa and SHANGHAI, Sept. 23, 2025 /PRNewswire/ -- Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the q...
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
SALT LAKE CITY and BOSTON, Sept. 23, 2025 /PRNewswire/ -- Myriad Genetics
Kelun-Biotech to Present Results from Multiple Clinical Studies at the 2025 ESMO Congress
CHENGDU, China, Sept. 23, 2025 /PRNewswire/ -- The 2025 European Society for Medical Oncology (ESMO) Congress will take place inBerlin, Germany, from October 17 to 21. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990) will present results from multiple clinical stud...
Kelun-Biotech's New Drug Application for Its Novel Next-generation Selective RET Inhibitor A400/EP0031 Accepted for Review by the NMPA for the Treatment of RET-fusion positive NSCLC
CHENGDU, China, Sept. 23, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that a new drug application (NDA) for the Company's small molecule rearranged during transfection (RET) kinase inhibitor A400 (also known as EP0031) was accepted for review ...
ObesityConnects, an Obesity-Fighting Platform to Connect Patients with Treatment for Sustainable Good Health
The Chulalongkorn Bariatric and Metabolic Institute (Chula BMI)
Angel Yeast's Breakthrough in Yeast Protein Research: AngeoPro Shown to Promote Calcium Absorption, Aiding in Osteoporosis Prevention
YICHANG, China, Sept. 23, 2025 /PRNewswire/ -- Angel Yeast
Week's Top Stories
Most Reposted
Radisson Hotel Group accelerates growth in Indonesia with ANTA Hotel Bali Canggu, a member of Radisson Individuals
[Picked up by 313 media titles]
2025-12-10 10:00HKSTP Makes Strategic Investment in Singapore Technology Company Vizzio; Forges Innovation Pact to Power Next-Generation AI and Smart City
[Picked up by 306 media titles]
2025-12-09 13:31ARKANCE to Launch BIMLOGIQ - A New AI-Powered Extension to Its AEC Tech Stack Offering
[Picked up by 293 media titles]
2025-12-11 09:07Tiiny AI Reveals World's Smallest Personal AI Supercomputer, Verified by Guinness World Records
[Picked up by 285 media titles]
2025-12-10 16:00Asia Pacific Defies Global Headwinds: Mastercard Economics Institute 2026 Outlook
[Picked up by 277 media titles]
2025-12-10 09:00